Novel Therapies in the Management of HER2-Positive Breast Cancer

Interview with Reshma L. Mahtani DO

Pet Therapy: How the Cat I Never Wanted Saved My Life – The ASCO Post

Fumiko Chino, MD My husband and I adopted our cat, Franklin, on a cold November day. It was one of the last days Andrew felt well enough to leave the house to go anywhere other than to chemotherapy or a doctor’s appointment. Our news at these appointments had shifted toward the negative, with disease progression on…

Agenus Announces ESMO Oral Presentation of Two Clinical Trials of Balstilimab Alone and in Combination with Zalifrelimab in Recurrent or Metastatic Cervical Cancer

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers…

Past CMS and FDA Head Discusses Challenges in U.S. Health-Care Policy and Possible Solutions – The ASCO Post

A Conversation With Mark McClellan, MD, PhD Mark McClellan, MD, PhD As evidenced at this year’s ASCO20 Virtual Scientific Program, oncology science, technology, and clinical practice are evolving at a rapid pace, bringing new challenges to the efficient and ethical practice of cancer care at all levels. To shed light on…

Single radiotherapy dose effective for breast cancer

A single dose of targeted radiotherapy during a lumpectomy procedure proved effective in a long-term clinical trial of thousands of women with early-stage breast cancer. The international team behind the large, randomized trial published their results on August 19 in the BMJ.

At Death’s Door

Prior History of SCC Could Be a Red Flag for Development of SCC in the Setting of CLL – Cancer Therapy Advisor

In this study, a cohort of patients with newly diagnosed CLL was followed to identify the incidence of SCC skin cancer and its associated risk factors in this population.

Developing Policies to Address Patient Racial Bias and Race-Based Provider Requests – The ASCO Post

Twist Bioscience: overcoming the challenges in precision medicine

Dr Emily Leproust (Twist Bioscience, CA, USA) discusses how Twist Bioscience products can be used in the fight against cancer

Chemotherapy and COVID-19 Outcomes in Patients With Cancer at Memorial Sloan Kettering Cancer Center – The ASCO Post